These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. High rate of vaginal infections caused by non-C. albicans Candida species among asymptomatic women. Dan M; Poch F; Levin D Med Mycol; 2002 Aug; 40(4):383-6. PubMed ID: 12230217 [TBL] [Abstract][Full Text] [Related]
11. Novel Preclinical Study of Galloylquinic Acid Compounds from Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130 [TBL] [Abstract][Full Text] [Related]
12. [Study on the relationship between vaginal and intestinal candida in patients with vulvovaginal candidiasis]. Lin XL; Li Z; Zuo XL Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):496-500. PubMed ID: 22041440 [TBL] [Abstract][Full Text] [Related]
13. Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy. Sun Z; Ge X; Qiu B; Xiang Z; Jiang C; Wu J; Li Y Front Cell Infect Microbiol; 2023; 13():1123026. PubMed ID: 36816582 [TBL] [Abstract][Full Text] [Related]
14. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis. Giraldo P; von Nowaskonski A; Gomes FA; Linhares I; Neves NA; Witkin SS Obstet Gynecol; 2000 Mar; 95(3):413-6. PubMed ID: 10711554 [TBL] [Abstract][Full Text] [Related]
16. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related]
17. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis. Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431 [TBL] [Abstract][Full Text] [Related]
18. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC). Donders GG; Grinceviciene S; Ruban K; Bellen G Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115024. PubMed ID: 32253071 [TBL] [Abstract][Full Text] [Related]
19. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis. Zhang X; Li T; Chen X; Wang S; Liu Z BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236 [TBL] [Abstract][Full Text] [Related]